Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kouichi Shiraishi

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Nanomedicine (London, England)|July 29, 2025
Considering the immunogenicity of PEG: strategies for overcoming issues with PEGylated nanomedicinesKouichi Shiraishi
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|December 3, 2013
[Utilization of polymeric micelle magnetic resonance imaging (MRI) contrast agent for theranostic system]Kouichi Shiraishi
ACS Bio & Med Chem Au|February 24, 2025
Antigenicity Extension: A Novel Concept Explained by the Immunogenicity of PEGKouichi Shiraishi, Masayuki Yokoyama
Biological & Pharmaceutical Bulletin|June 4, 2013
Polymeric micelles possessing polyethyleneglycol as outer shell and their unique behaviors in accelerated blood clearance phenomenonKouichi Shiraishi, Masayuki Yokoyama
Science and Technology of Advanced Materials|May 10, 2019
Toxicity and immunogenicity concerns related to PEGylated-micelle carrier systems: a reviewKouichi Shiraishi, Masayuki Yokoyama
Magma (New York, N.Y.)|December 12, 2019
Stability evaluation of Gd chelates for macromolecular MRI contrast agentsMasayuki Yokoyama, Kouichi Shiraishi
ACS Omega|August 19, 2024
Impact of the Hydrophilicity of Poly(sarcosine) on Poly(ethylene glycol) (PEG) for the Suppression of Anti-PEG Antibody BindingDebabrata Maiti, Masayuki Yokoyama, Kouichi Shiraishi
Chemical Communications (Cambridge, England)|July 15, 2009
Stable diarylnitroxide diradical with triplet ground stateAndrzej Rajca, Kouichi Shiraishi, Suchada Rajca
Journal of Pharmaceutical Sciences|December 30, 2009
The combretastatin derivative (Cderiv), a vascular disrupting agent, enables polymeric nanomicelles to accumulate in microtumorsKatsuyoshi Hori, Masamichi Nishihara, Kouichi Shiraishi, et al.
Journal of the American Chemical Society|June 30, 2005
pi-Conjugated conjoined double helicene via a sequence of three oxidative CC- and NN-homocouplingsKouichi Shiraishi, Andrzej Rajca, Maren Pink, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Nanomedicine (London, England)|July 29, 2025
Considering the immunogenicity of PEG: strategies for overcoming issues with PEGylated nanomedicinesKouichi Shiraishi
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|December 3, 2013
[Utilization of polymeric micelle magnetic resonance imaging (MRI) contrast agent for theranostic system]Kouichi Shiraishi
ACS Bio & Med Chem Au|February 24, 2025
Antigenicity Extension: A Novel Concept Explained by the Immunogenicity of PEGKouichi Shiraishi, Masayuki Yokoyama
Biological & Pharmaceutical Bulletin|June 4, 2013
Polymeric micelles possessing polyethyleneglycol as outer shell and their unique behaviors in accelerated blood clearance phenomenonKouichi Shiraishi, Masayuki Yokoyama
Science and Technology of Advanced Materials|May 10, 2019
Toxicity and immunogenicity concerns related to PEGylated-micelle carrier systems: a reviewKouichi Shiraishi, Masayuki Yokoyama
Magma (New York, N.Y.)|December 12, 2019
Stability evaluation of Gd chelates for macromolecular MRI contrast agentsMasayuki Yokoyama, Kouichi Shiraishi
ACS Omega|August 19, 2024
Impact of the Hydrophilicity of Poly(sarcosine) on Poly(ethylene glycol) (PEG) for the Suppression of Anti-PEG Antibody BindingDebabrata Maiti, Masayuki Yokoyama, Kouichi Shiraishi
Chemical Communications (Cambridge, England)|July 15, 2009
Stable diarylnitroxide diradical with triplet ground stateAndrzej Rajca, Kouichi Shiraishi, Suchada Rajca
Journal of Pharmaceutical Sciences|December 30, 2009
The combretastatin derivative (Cderiv), a vascular disrupting agent, enables polymeric nanomicelles to accumulate in microtumorsKatsuyoshi Hori, Masamichi Nishihara, Kouichi Shiraishi, et al.
Journal of the American Chemical Society|June 30, 2005
pi-Conjugated conjoined double helicene via a sequence of three oxidative CC- and NN-homocouplingsKouichi Shiraishi, Andrzej Rajca, Maren Pink, et al.
Pageof 4